Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea
· Delayed Price · Currency is KRW
8,700.00
-40.00 (-0.46%)
At close: Mar 9, 2026
Pharos iBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 112,630 | 98,001 | 191,588 | - | - | - | |
| Market Cap Growth | -3.87% | -48.85% | - | - | - | - | |
| Enterprise Value | 103,992 | 80,945 | 164,210 | - | - | - | |
| Last Close Price | 8700.00 | 7570.00 | 14830.00 | - | - | - | |
| PB Ratio | 9.88 | 5.27 | 6.76 | - | - | - | |
| P/TBV Ratio | 10.23 | 5.39 | 6.79 | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.02 | -0.04 | -0.68 | |
| Net Debt / Equity Ratio | -0.76 | -0.83 | -0.89 | -0.83 | 1.47 | 16.44 | |
| Net Debt / EBITDA Ratio | 0.81 | 1.32 | 2.67 | 1.47 | 2.88 | 2.41 | |
| Net Debt / FCF Ratio | 1.00 | 1.55 | 3.05 | 1.73 | 2.74 | 2.56 | |
| Asset Turnover | - | - | - | 0.01 | 0.00 | 0.02 | |
| Quick Ratio | 10.97 | 16.25 | 21.15 | 16.06 | 0.56 | 0.86 | |
| Current Ratio | 11.32 | 16.70 | 21.57 | 16.53 | 0.57 | 0.88 | |
| Return on Equity (ROE) | -61.86% | -44.97% | -38.50% | -1825.61% | - | - | |
| Return on Assets (ROA) | -42.99% | -31.94% | -26.12% | -28.73% | -23.78% | -32.64% | |
| Return on Capital Employed (ROCE) | -99.30% | -67.50% | -35.50% | -59.80% | 55.20% | 1120.40% | |
| Earnings Yield | -8.72% | -10.78% | -4.62% | - | - | - | |
| FCF Yield | -7.65% | -10.21% | -4.31% | - | - | - | |
| Buyback Yield / Dilution | -0.13% | -6.79% | -36.26% | -53.03% | -2.65% | -1.86% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.